HOUT-25. ADHERENCE TO TUMOR TREATING FIELDS IN PATIENTS WITH HIGH-GRADE GLIOMA – A SINGLE CENTER EXPERIENCE

BACKGROUND: The addition of alternating electric fields with low intensity (1–3 V/cm) and intermediate frequency (100–300 kHz), known as Tumor Treating Fields (TTFields), to adjuvant temozolomide demonstrated significant clinical benefits in newly diagnosed glioblastoma (GBM) patients. Post-hoc anal...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Kessler, Almuth, Weiland, Judith, Breun, Maria, Linsenmann, Thomas, Ernestus, Rolf-Ingo, Hagemann, Carsten, Löhr, Mario
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2018
Pynciau:
Abstracts
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6217232/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy148.493
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg